Weight significantly impacts cardiovascular risk, especially excess abdominal fat, which raises the chances of high blood pressure, high cholesterol, and insulin resistance—major contributors to heart disease. Fortunately, advanced weight loss treatments now not only help shed pounds but also enhance metabolic and heart health.

Among the most promising advances are GLP-1 receptor agonists like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound). These medications promote sustainable weight loss while improving cardiovascular health, making them a game-changer for reducing heart disease risk.

Carrying excess weight—especially visceral fat stored around internal organs—raises several risk factors for cardiovascular disease, including:

• High Blood Pressure – Excess weight puts added strain on the heart and raises blood pressure.
• Elevated Cholesterol – Obesity disrupts cholesterol balance, increasing the risk of plaque buildup in the arteries.
• Insulin Resistance & Type 2 Diabetes – Excess fat makes it harder for the body to regulate blood sugar, which increases cardiovascular risk.
• Inflammation – Obesity triggers chronic inflammation, which contributes to atherosclerosis (narrowing of the arteries).

Losing just 5–10% of body weight can significantly lower these risks. GLP-1 medications help make this level of weight loss more achievable and sustainable.

Researchers initially developed GLP-1 receptor agonists to manage blood sugar in people with Type 2 diabetes, but they quickly discovered the medications’ powerful benefits for weight loss and heart health. Here’s how these medications work:

1. Appetite Regulation for Sustainable Weight Loss
   GLP-1 medications mimic a hormone that signals fullness to the brain. They reduce hunger and help individuals eat fewer calories without relying on extreme dieting. As a result, people experience steady weight loss, which reduces strain on the heart and improves overall metabolic function.
2. Cholesterol & Blood Pressure Improvement
   Studies show that GLP-1 medications lower LDL (“bad”) cholesterol and triglycerides while promoting healthy levels of HDL (“good”) cholesterol. Additionally, the weight loss achieved with these medications helps lower blood pressure, further reducing cardiovascular strain.
3. Reduction in Inflammation and Arterial Plaque
   Carrying excess fat triggers chronic low-grade inflammation, which contributes to plaque buildup in the arteries. By promoting weight loss and lowering blood sugar, GLP-1 medications help reduce inflammation and improve arterial function, lowering the risk of heart attacks and strokes.
4. Improved Blood Sugar Control and Insulin Sensitivity
   Because insulin resistance plays a major role in cardiovascular disease, controlling blood sugar is essential. GLP-1 medications stabilize blood sugar levels and improve insulin sensitivity, helping reduce the risk of diabetes-related heart complications.

At Peak Medical, we provide compounded Semaglutide and Tirzepatide, offering our patients a high-quality, personalized approach to GLP-1 therapy.

What Are Compounded Medications?
Licensed compounding pharmacies custom-formulate these medications to deliver the same active ingredients as brand-name GLP-1 medications—while also offering additional benefits:

• Increased Availability – Compounded medications help you avoid shortages that often affect brand-name options like Ozempic and Wegovy.

• Personalized Dosages – We adjust dosages to meet your specific needs, optimizing results and minimizing side effects.

• More Affordable – Compounded options often cost less than commercial alternatives, making it easier for you to maintain your treatment long-term.

Compounded GLP-1 medications deliver the same powerful weight loss and heart health benefits while tailoring treatment to individual needs. At Peak Medical, we partner with trusted compounding pharmacies to ensure our patients receive safe, effective, and affordable care.

For many people, losing weight isn’t just about looking better—it’s about feeling better and lowering serious health risks. Research and real-world patient experiences show that GLP-1 medications do more than promote weight loss—they actively protect the heart.

• A Game-Changer for Heart Health – A major study found that patients who took Semaglutide reduced their risk of major heart events, such as heart attacks and strokes, by 20% compared to those who didn’t take the medication.
• Lower Cholesterol & Blood Pressure – Patients who lost weight using GLP-1 medications also experienced significant drops in LDL cholesterol and blood pressure, both key risk factors for heart disease.

A Real Difference for Patients – Many individuals who have struggled with weight-related health issues for years find that GLP-1 therapy helps them lose weight, improve their energy levels, and reduce their reliance on medications for high blood pressure and cholesterol.

By supporting sustainable weight loss and heart health, GLP-1 medications are helping patients at Peak Medical and across the country live longer, healthier lives.

GLP-1 receptor agonists may be a good fit for individuals who:

• Have struggled with weight loss despite lifestyle changes.
•  Have high cholesterol, high blood pressure, or prediabetes.
• Are at risk for or have been diagnosed with heart disease.
• Have Type 2 diabetes and want additional cardiovascular protection.

At Peak Medical, we are committed to helping you achieve long-term weight loss and improved heart health with the latest medical advancements. If you’re interested in learning more about GLP-1 medications like Semaglutide or Tirzepatide, our expert providers can create a personalized plan to help you reduce your heart disease risk and reach your health goals.

Take the first step toward a healthier heart today! Contact Peak Medical to schedule your consultation and start your journey to lasting wellness and longevity.

📞 Call us today! 435-602-1034
🌐 Follow us on social media for health tips, promotions, and more!